SCHEMBL25367402

SCHEMBL25367402

N#Cc1cccc(-c2nc(N)sc2-c2ccc3nccn3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.44
ALDH1A3 P47895 1/20 0.44
TRIM33 Q9UPN9 3/20 0.41
TGFBR1 P36897 3/20 0.41
TGFBR2 P37173 1/20 0.41
ADORA2A P29274 4/20 0.40
ALDH1A1 P00352 3/20 0.40
ADORA1 P30542 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
ADORA3 P0DMS8 2/20 0.38
CYP3A4 P08684 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30520046 1.00 DYRK1A (0.44) DYRK1AALDH1A3TRIM33TGFBR1TGFBR2
SCHEMBL18042041 0.84 TGFBR1 (0.52) DYRK1ATGFBR1TGFBR2ALDH1A1MAPT
SCHEMBL18057147 0.84 TGFBR1 (0.58) DYRK1ATGFBR1TGFBR2ALDH1A1MAPT
SCHEMBL18041581 0.84 DYRK1A (0.47) DYRK1ATGFBR1TGFBR2ADORA2AALDH1A1
SCHEMBL30519842 0.83 ALDH1A1 (0.45) ALDH1A3TGFBR1ADORA2AALDH1A1ADORA1
SCHEMBL25365138 0.83 ALDH1A1 (0.45) ALDH1A3TGFBR1ADORA2AALDH1A1ADORA1
SCHEMBL18041778 0.82 DYRK1A (0.45) DYRK1AALDH1A3TRIM33TGFBR1TGFBR2
SCHEMBL29677055 0.82 DYRK1A (0.45) DYRK1AALDH1A3TRIM33TGFBR1TGFBR2
SCHEMBL29677091 0.81 RET (0.46) DYRK1ATGFBR1TGFBR2ADORA2AALDH1A1
SCHEMBL18041923 0.81 RET (0.46) DYRK1ATGFBR1TGFBR2ADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243194-A1 ANTAGONIST OF ADENOSINE RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2025-07-31 US disclosed
WO-2023144559-A1 ANTAGONIST OF ADENOSINE RECEPTORS AdoRx Therapeutics Limited (GB) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250243194-A1 ANTAGONIST OF ADENOSINE RECEPTORS ADORA2B, ADORA2A, ADORA1 DYRK1A 1526/4885ALDH1A3 1483/4885TRIM33 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.